Ethoheptazine citrate

Pericyazine (Propericiazine) is a selective D2-dopamine receptor antagonist. Pericyazine is a first-generation antipsychotic drug that is used as an adjunct to the short-term management of severe anxiety states and psychosis.

Pericyazine (Propericiazine) is a selective D2-dopamine receptor antagonist. Pericyazine is a first-generation antipsychotic drug that is used as an adjunct to the short-term management of severe anxiety states and psychosis.

Pericyazine (Propericiazine) is a selective D2-dopamine receptor antagonist. Pericyazine is a first-generation antipsychotic drug that is used as an adjunct to the short-term management of severe anxiety states and psychosis.

Tandospirone citrate is a potent and selective 5-HT1A receptor partial agonist (Ki = 27 nM) that displays selectivity over SR-2, SR-1C, α1, α2, D1 and D2 receptors (Ki values ranging from 1300-41000 nM).IC50 Value: 27±5 nM(Ki) Target: 5-HT1Ain

Tandospirone citrate is a potent and selective 5-HT1A receptor partial agonist (Ki = 27 nM) that displays selectivity over SR-2, SR-1C, α1, α2, D1 and D2 receptors (Ki values ranging from 1300-41000 nM).IC50 Value: 27±5 nM(Ki) Target: 5-HT1Ain

Tandospirone citrate is a potent and selective 5-HT1A receptor partial agonist (Ki = 27 nM) that displays selectivity over SR-2, SR-1C, α1, α2, D1 and D2 receptors (Ki values ranging from 1300-41000 nM).IC50 Value: 27±5 nM(Ki) Target: 5-HT1Ain

Tandospirone citrate is a potent and selective 5-HT1A receptor partial agonist (Ki = 27 nM) that displays selectivity over SR-2, SR-1C, α1, α2, D1 and D2 receptors (Ki values ranging from 1300-41000 nM).IC50 Value: 27±5 nM(Ki) Target: 5-HT1Ain

Tandospirone citrate is a potent and selective 5-HT1A receptor partial agonist (Ki = 27 nM) that displays selectivity over SR-2, SR-1C, α1, α2, D1 and D2 receptors (Ki values ranging from 1300-41000 nM).IC50 Value: 27±5 nM(Ki) Target: 5-HT1Ain

Tetrabenazine Racemate (Ro 1-9569 Racemate) is a selective and reversible inhibitor of vesicular monoamine transporter-2 (VMAT-2).(1) The reference for administration is 0.25-0.75 mg/kg IP (2) Injections of tetrabenazine into accumbens core also

TG6-10-1 is an EP2 antagonist, shows low-nanomolar antagonist activity against only EP2, &gt:300-fold selectivity over human EP3, EP4, and IP receptors, 100-fold selectivity over EP1 receptorsIn VitroTG6-10-1 robustly blocks prostaglandin E2 (PGE2)

TG6-10-1 is an EP2 antagonist, shows low-nanomolar antagonist activity against only EP2, &gt:300-fold selectivity over human EP3, EP4, and IP receptors, 100-fold selectivity over EP1 receptorsIn VitroTG6-10-1 robustly blocks prostaglandin E2 (PGE2)

TG6-10-1 is an EP2 antagonist, shows low-nanomolar antagonist activity against only EP2, &gt:300-fold selectivity over human EP3, EP4, and IP receptors, 100-fold selectivity over EP1 receptorsIn VitroTG6-10-1 robustly blocks prostaglandin E2 (PGE2)